Decagonal pKPL: shaping up to transplant success

Article

Using a decagonal transplant shape in perforating keratoplasties (pKPL) delivers promising results.

Using a decagonal transplant shape in perforating keratoplasties (pKPL) delivers promising results, says Mark Tomalla from the Clinic for Refractive and Ophthalmic Surgery, Duisburg, Germany.

Dr Tomalla and colleagues have performed 30 pKPL procedures using the Femtec femtosecond laser (20/10 Perfect Vision) over the past two years and have been satisfied with the postoperative results. As a further development, however, the researchers wanted to investigate the optimal transplant shape.

Three pKPL procedures with a decagonal transplant shape have so far been carried out, demonstrating a fit precision of 1/100 mm on the recipient cornea. After two months mean astigmatisms were 2 D and have remained stable since. Fine Descemet folds were visible immediately after surgery but these disappeared after approximately two weeks.

Dr Tomalla believes that the use of non-circular transplant shapes, such as the decagonal shape, is a promising approach to pKPL.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.